ATE151423T1 - Carbocyclische nucleoside mittel nützlich als selektive inhibitoren von proinflammatorischen cytokinen - Google Patents

Carbocyclische nucleoside mittel nützlich als selektive inhibitoren von proinflammatorischen cytokinen

Info

Publication number
ATE151423T1
ATE151423T1 AT94918130T AT94918130T ATE151423T1 AT E151423 T1 ATE151423 T1 AT E151423T1 AT 94918130 T AT94918130 T AT 94918130T AT 94918130 T AT94918130 T AT 94918130T AT E151423 T1 ATE151423 T1 AT E151423T1
Authority
AT
Austria
Prior art keywords
alkyl
compounds
substituent
agents useful
selective inhibitors
Prior art date
Application number
AT94918130T
Other languages
English (en)
Inventor
Carl K Edwards Iii
David R Borcherding
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE151423T1 publication Critical patent/ATE151423T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT94918130T 1993-06-21 1994-05-25 Carbocyclische nucleoside mittel nützlich als selektive inhibitoren von proinflammatorischen cytokinen ATE151423T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8024993A 1993-06-21 1993-06-21

Publications (1)

Publication Number Publication Date
ATE151423T1 true ATE151423T1 (de) 1997-04-15

Family

ID=22156170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918130T ATE151423T1 (de) 1993-06-21 1994-05-25 Carbocyclische nucleoside mittel nützlich als selektive inhibitoren von proinflammatorischen cytokinen

Country Status (20)

Country Link
US (1) US6541482B2 (de)
EP (1) EP0705263B1 (de)
JP (1) JP3479077B2 (de)
KR (1) KR100337720B1 (de)
CN (1) CN1041631C (de)
AT (1) ATE151423T1 (de)
AU (1) AU677851B2 (de)
CA (1) CA2165779C (de)
DE (1) DE69402548T2 (de)
DK (1) DK0705263T3 (de)
ES (1) ES2103131T3 (de)
FI (1) FI956142A0 (de)
GR (1) GR3023373T3 (de)
HU (1) HUT73412A (de)
IL (1) IL110041A0 (de)
NO (1) NO312836B1 (de)
NZ (1) NZ267322A (de)
TW (1) TW356471B (de)
WO (1) WO1995000514A1 (de)
ZA (1) ZA944256B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111497D0 (en) * 2001-05-11 2001-07-04 Medical Res Council Therapeutic methods
GB0114286D0 (en) * 2001-06-12 2001-08-01 Hoffmann La Roche Nucleoside Derivatives
AU2003299441A1 (en) * 2002-12-19 2004-07-14 Centre National De La Recherche Scientifique - Cnrs Nf-hev compositions and methods of use
US7517887B2 (en) 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
US7868011B2 (en) 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
US7196093B2 (en) * 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
US11033821B2 (en) 2003-09-02 2021-06-15 Jeffrey D. Mullen Systems and methods for location based games and employment of the same on location enabled devices
GEP20105024B (en) * 2004-06-02 2010-06-25 Takeda Pharmaceuticals Co Fused heterocyclic compound

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164556B (de) 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US4916224A (en) 1988-01-20 1990-04-10 Regents Of The University Of Minnesota Dideoxycarbocyclic nucleosides
US4931559A (en) 1988-01-20 1990-06-05 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
CA2051012C (en) * 1990-09-14 2002-04-02 David R. Borcherding Carbocyclic adenosine analogs useful as immunosupressants
AU642526B2 (en) 1990-09-14 1993-10-21 Marion Merrell Dow Inc. Method of immunosuppression using cyclopentenyl substituted nucleoside analogs and compositions thereof
US5332814A (en) * 1991-11-12 1994-07-26 Ciba-Geigy Corporation Process for the preparation of carbacyclic nucleosides, and intermediates
AU658698B2 (en) 1991-12-06 1995-04-27 Aventis Pharmaceuticals Inc. Novel trans cyclopentanyl purine analogs useful as immunosuppressants
GB9204015D0 (en) * 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides
SK284810B6 (sk) * 1997-05-13 2005-12-01 Lonza Ag Spôsob výroby (1S,4R)- alebo (1R,4S)-4-(2-amino-6-chlór-9-H- purín-9-yl)-2-cyklopentén-1-metanolu
JPH11255768A (ja) * 1998-03-09 1999-09-21 Ajinomoto Co Inc 抗ウイルス剤の製造方法

Also Published As

Publication number Publication date
FI956142A (fi) 1995-12-20
DE69402548D1 (de) 1997-05-15
NO955197L (no) 1996-02-16
FI956142A0 (fi) 1995-12-20
WO1995000514A1 (en) 1995-01-05
HU9503689D0 (en) 1996-02-28
CN1041631C (zh) 1999-01-13
DK0705263T3 (da) 1997-05-05
ZA944256B (en) 1995-02-08
US20020004508A1 (en) 2002-01-10
NO312836B1 (no) 2002-07-08
IL110041A0 (en) 1994-10-07
KR100337720B1 (ko) 2002-11-02
CA2165779A1 (en) 1995-01-05
ES2103131T3 (es) 1997-08-16
CN1125946A (zh) 1996-07-03
JP3479077B2 (ja) 2003-12-15
CA2165779C (en) 1998-06-16
EP0705263A1 (de) 1996-04-10
DE69402548T2 (de) 1997-07-17
HUT73412A (en) 1996-07-29
EP0705263B1 (de) 1997-04-09
AU677851B2 (en) 1997-05-08
AU6958394A (en) 1995-01-17
GR3023373T3 (en) 1997-08-29
NO955197D0 (no) 1995-12-20
TW356471B (en) 1999-04-21
JPH08511558A (ja) 1996-12-03
KR960703122A (ko) 1996-06-19
US6541482B2 (en) 2003-04-01
NZ267322A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
ES2067500T3 (es) 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.
HUP0003250A1 (hu) Káliumcsatorna gátló hatású indánszármazékok és az ezeket tartalmazó gyógyszerkészítmények
HUP0204474A2 (hu) 1H-imidazopiridin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ES2188280T3 (es) Acetales heteroaril-ciclicos.
HUP0303624A2 (hu) NEP inhibitor hatású N-fenpropil-ciklopentil-csoporttal szubsztituált glutáramid származékok és ezeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
EP0363085A3 (de) Chemische Verbindungen
EA200000320A1 (ru) Изохинолины в качестве ингибиторов урокиназы
ATE151423T1 (de) Carbocyclische nucleoside mittel nützlich als selektive inhibitoren von proinflammatorischen cytokinen
FI953935A0 (fi) Polyamiinijohdannaisia radiosuojaavina aineina
HUP0201722A2 (hu) Gyógyászati készítmények alkoholizmus és alkoholfüggőség kezelésére
ATE182889T1 (de) Bicyclische amidinderivate als no-synthetase inhibitoren
RU96114993A (ru) Производные n-замещенного 3-азабицикло[3.2.0]гептана
TW333532B (en) Benzopyrans
HUP9900246A2 (hu) Liofilizált tio-xantenont tartalmazó tumorellenes gyógyszerkészítmények
NO991833L (no) Bis (acridincarboksamid) og bis (fenazincarboksamid) som antitumormidler
MY131365A (en) Carbamic acid derivatives
DK0475413T3 (da) Carbocycliske nukleosidanaloge, der kan anvendes som immunsuppressorer
HUP9700558A2 (hu) Mikrobicid készítmények

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee